首页 | 本学科首页   官方微博 | 高级检索  
     

帕瑞昔布钠联合右美托咪定预防腹部闭合性损伤手术患者苏醒期躁动
引用本文:张金立,闫红丽,杨凯,李永乐,郝捷. 帕瑞昔布钠联合右美托咪定预防腹部闭合性损伤手术患者苏醒期躁动[J]. 医学研究与教育, 2020, 37(4): 25-30. DOI: 10.3969/j.issn.1674-490X.2020.04.005
作者姓名:张金立  闫红丽  杨凯  李永乐  郝捷
作者单位:1.保定市第一中心医院麻醉科, 河北 保定 071051;2.河北大学附属医院, 河北 保定 071000;3.保定市第二医院外科, 河北 保定 071005
基金项目:保定市科学技术研究与发展指导计划
摘    要:目的 探讨帕瑞昔布钠单独或联合右美托咪定用于预防腹部闭合性损伤手术患者苏醒期躁动(emergence agitation, EA)的效果及对炎性因子的影响。方法 选全麻下行腹部闭合性损伤开放手术患者125例,最终帕瑞昔布钠联合右美托咪定组(PD组)41例、帕瑞昔布钠组(P组)45例、生理盐水组(C组)39例。PD组、P组、C组分别于手术结束前30 min静脉滴注右美托咪定+帕瑞昔布钠、帕瑞昔布钠及等量生理盐水。观察EA发生率,呼吸恢复时间、苏醒时间、拔管时间、血流动力学指标、炎性因子水平。结果(1)PD组、P组EA发生率显著低于C组;PD组Ramsay镇静评分显著高于P组、C组,Riker镇静躁动评分、PARD评分显著低于P组、C组;(2)3组呼吸恢复时间、苏醒时间、拔管时间比较差异无统计学意义;(3)T1、T2时PD组、P组MAP、HR显著低于C组;(4)PD组、P组T1、T2时血清TNF-1α、IL-6显著低于C组,IL-10水平显著高于C组。结论 腹部闭合性损伤全麻术中帕瑞昔布钠单用或与右美托咪定联用均能预防EA发生,呼吸恢复、苏醒时间及拔管时间未见明显延长,血流动力学指标稳定,对炎症反应有一定抑制作用,且联合用药效果优于单用。

关 键 词:帕瑞昔布钠  右美托咪定  苏醒期躁动  腹部闭合性损伤  炎性因子  
收稿时间:2019-12-31

Clinical observation of emergence agitation of parecoxib sodium combined with dexmedetomidine on pa-tients undergoing closed abdominal injury surgery
ZHANG Jinli,YAN Hongli,YANG Kai,LI Yongle,HAO Jie. Clinical observation of emergence agitation of parecoxib sodium combined with dexmedetomidine on pa-tients undergoing closed abdominal injury surgery[J]. Medical Research and Education, 2020, 37(4): 25-30. DOI: 10.3969/j.issn.1674-490X.2020.04.005
Authors:ZHANG Jinli  YAN Hongli  YANG Kai  LI Yongle  HAO Jie
Abstract:Objective To investigate the effect of parecoxib sodium alone or in combination with dexmedetomidine in preventing emergence agitation(emergence agitation, EA)in patients undergoing closed abdominal injury surgery and its influence on inflammatory factors. Methods 125 patients with closed abdominal injury underwent open surgery under general anesthesia were selected, they were divided into parecoxib sodium combined with dextropyrimidine group(PD group,41 cases), parecoxib sodium group(P group, 45 cases)and saline group(C group, 39 cases). The subjects in the PD group, P group, C group were injected with dexmedetomidine+parecoxib sodium, parecoxib sodium and equal saline 30 minutes before the end of operation respectively. The incidence of EA, recovery time of breathing, recovery time, extubation time, hemodynamic parameters and inflammatory factorslevel were observed. Results(1)The incidence of EA in PD group, P group was significantly lower than that in C group, Ramsay sedation score in PD group was significantly higher than that in P group, C group, Riker sedation and restlessness score and PARD score were significantly lower than those in P group, C group.(2)There was no significant difference in respiratory recovery time, recovery time and extubation time among the three groups.(3)At T1 and T2, MAP and HR in PD group, P groups were significantly lower than those in C group.(4)Serum TNF-1α and IL-6 levels in PD group, P groups at T1 and T2 were significantly lower than those in C group, and IL-10 levels were significantly higher than those in C group. Conclusion During general anesthesia for closed abdominal injury, parecoxib sodium alone or in combination with dexmedetomidine can prevent EA, respiratory recovery, recovery time and extubation time have not been significantly prolonged, hemodynamic parameters are stable and inflammation reaction has been inhibited. And the effects of combined use are better than that of single use.
Keywords:parecoxib sodium  dexmedetomidine  emergence agitation  closed abdominal injury  inflammatory factors  
本文献已被 万方数据 等数据库收录!
点击此处可从《医学研究与教育》浏览原始摘要信息
点击此处可从《医学研究与教育》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号